Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Cancers|November 28, 2013
The "two-faced" effects of reactive oxygen species and the lipid peroxidation product 4-hydroxynonenal in the hallmarks of cancerStefania Pizzimenti, Cristina Toaldo, Piergiorgio Pettazzoni, et al.
PPAR Research|July 11, 2008
The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation ProductsGiuseppina Barrera, Cristina Toaldo, Stefania Pizzimenti, et al.
Free Radical Biology & Medicine|November 22, 2008
MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidationStefania Pizzimenti, Manuela Ferracin, Silvia Sabbioni, et al.
Cancer Biology & Therapy|March 10, 2009
Increase of telomerase activity and hTERT expression in myelodysplastic syndromesFederica Briatore, Giuseppina Barrera, Stefania Pizzimenti, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 25, 2012
Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cellsRosalba Minelli, Roberta Cavalli, Leigh Ellis, et al.
Frontiers in Physiology|September 13, 2013
Interaction of aldehydes derived from lipid peroxidation and membrane proteinsStefania Pizzimenti, Eric Ciamporcero, Martina Daga, et al.
Biomed Research International|March 1, 2021
Corrigendum to "Drug Delivery Nanoparticles in Skin Cancers"Chiara Dianzani, Gian Paolo Zara, Giovanni Maina, et al.
Journal of Cellular and Molecular Medicine|November 17, 2009
PPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network in colon cancer cellsCristina Toaldo, Stefania Pizzimenti, Angelo Cerbone, et al.
Biomed Research International|August 8, 2014
Drug delivery nanoparticles in skin cancersChiara Dianzani, Gian Paolo Zara, Giovanni Maina, et al.
Pageof 4